Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garner

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
FEBS Letters|May 25, 2011
Ubiquitylation and the Fanconi anemia pathwayElizabeth Garner, Agata Smogorzewska
DNA Repair|June 2, 2009
Studying the DNA damage response using in vitro model systemsElizabeth Garner, Vincenzo Costanzo
Cell Cycle (Georgetown, Tex.)|February 1, 2008
Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell deathElizabeth Garner, Kenneth Raj
Infectious Diseases in Obstetrics and Gynecology|July 21, 2007
The superinfection of a dermoid cystJanelle Luk, Alexander Quaas, Elizabeth Garner
Cancer Research|August 19, 2007
Cells with defective p53-p21-pRb pathway are susceptible to apoptosis induced by p84N5 via caspase-6Elizabeth Garner, Fabio Martinon, Jurg Tschopp, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 15, 2003
Psychosocial and reproductive outcomes of gestational trophoblastic diseasesElizabeth Garner, Donald P Goldstein, Ross S Berkowitz, et al.
Nature Cell Biology|April 13, 2010
GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replicationAlessia Balestrini, Claudia Cosentino, Alessia Errico, et al.
The EMBO Journal|July 4, 2008
Mre11-Rad50-Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activityAli Jazayeri, Alessia Balestrini, Elizabeth Garner, et al.
Cell Reports|October 2, 2013
Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctionsElizabeth Garner, Yonghwan Kim, Francis P Lach, et al.
Reproductive Biomedicine Online|November 20, 2021
Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot studyJacques Donnez, Olivier Donnez, Michel Brethous, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
FEBS Letters|May 25, 2011
Ubiquitylation and the Fanconi anemia pathwayElizabeth Garner, Agata Smogorzewska
DNA Repair|June 2, 2009
Studying the DNA damage response using in vitro model systemsElizabeth Garner, Vincenzo Costanzo
Cell Cycle (Georgetown, Tex.)|February 1, 2008
Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell deathElizabeth Garner, Kenneth Raj
Infectious Diseases in Obstetrics and Gynecology|July 21, 2007
The superinfection of a dermoid cystJanelle Luk, Alexander Quaas, Elizabeth Garner
Cancer Research|August 19, 2007
Cells with defective p53-p21-pRb pathway are susceptible to apoptosis induced by p84N5 via caspase-6Elizabeth Garner, Fabio Martinon, Jurg Tschopp, et al.
Best Practice & Research. Clinical Obstetrics & Gynaecology|November 15, 2003
Psychosocial and reproductive outcomes of gestational trophoblastic diseasesElizabeth Garner, Donald P Goldstein, Ross S Berkowitz, et al.
Nature Cell Biology|April 13, 2010
GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replicationAlessia Balestrini, Claudia Cosentino, Alessia Errico, et al.
The EMBO Journal|July 4, 2008
Mre11-Rad50-Nbs1-dependent processing of DNA breaks generates oligonucleotides that stimulate ATM activityAli Jazayeri, Alessia Balestrini, Elizabeth Garner, et al.
Cell Reports|October 2, 2013
Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctionsElizabeth Garner, Yonghwan Kim, Francis P Lach, et al.
Reproductive Biomedicine Online|November 20, 2021
Treatment of symptomatic uterine adenomyosis with linzagolix, an oral gonadotrophin-releasing hormone antagonist: a pilot studyJacques Donnez, Olivier Donnez, Michel Brethous, et al.
Pageof 3